JP2012532868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532868A5 JP2012532868A5 JP2012519544A JP2012519544A JP2012532868A5 JP 2012532868 A5 JP2012532868 A5 JP 2012532868A5 JP 2012519544 A JP2012519544 A JP 2012519544A JP 2012519544 A JP2012519544 A JP 2012519544A JP 2012532868 A5 JP2012532868 A5 JP 2012532868A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- aryl
- compound
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22394609P | 2009-07-08 | 2009-07-08 | |
| US61/223,946 | 2009-07-08 | ||
| PCT/US2010/001926 WO2011005322A2 (en) | 2009-07-08 | 2010-07-08 | N-alkoxyamide conjugates as imaging agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532868A JP2012532868A (ja) | 2012-12-20 |
| JP2012532868A5 true JP2012532868A5 (enExample) | 2013-08-29 |
| JP5676600B2 JP5676600B2 (ja) | 2015-02-25 |
Family
ID=43429724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012519544A Expired - Fee Related JP5676600B2 (ja) | 2009-07-08 | 2010-07-08 | 造影剤としてのｎ−アルコキシアミド抱合体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8877157B2 (enExample) |
| EP (1) | EP2451776B1 (enExample) |
| JP (1) | JP5676600B2 (enExample) |
| CN (1) | CN102781909B (enExample) |
| AU (1) | AU2010271097B2 (enExample) |
| CA (1) | CA2803520C (enExample) |
| WO (1) | WO2011005322A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2474523T3 (da) | 2006-12-26 | 2020-07-13 | Lantheus Medical Imaging Inc | Ligander til billeddannelse af hjerte-innervation |
| KR101861025B1 (ko) | 2008-01-08 | 2018-05-24 | 랜티우스 메디컬 이메징, 인크. | 영상화 제제로서의 ｎ-알콕시아미드 접합체 |
| US8877157B2 (en) | 2009-07-08 | 2014-11-04 | Lantheus Medical Imaging, Inc. | N-alkoxyamide conjugates as imaging agents |
| CN106977429B (zh) | 2010-05-11 | 2021-08-24 | 蓝瑟斯医学影像公司 | 用于合成和使用造影剂的组合物、方法和系统 |
| GB201102189D0 (en) * | 2011-02-08 | 2011-03-23 | King S College London | Materials and methods relating to cardiovascular imaging |
| DK2753605T3 (da) | 2011-09-09 | 2019-06-17 | Lantheus Medical Imaging Inc | Sammensætninger, fremgangsmåder, og systemer til syntesen og anvendelsen af billeddannelsesmidler |
| US20150023873A1 (en) | 2011-11-11 | 2015-01-22 | Lantheus Medical Imaging, Inc. | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| WO2018092885A1 (ja) | 2016-11-18 | 2018-05-24 | アステラス製薬株式会社 | 新規な抗ヒトＭＵＣ１抗体Ｆａｂフラグメント |
| TWI795415B (zh) | 2017-07-07 | 2023-03-11 | 日商安斯泰來製藥股份有限公司 | 新穎的抗人類ＣＥＡＣＡＭ５抗體Ｆａｂ片段 |
| US12202908B2 (en) | 2018-05-17 | 2025-01-21 | Astellas Pharma Inc. | Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligand |
| MX2021004146A (es) | 2018-10-10 | 2021-06-08 | Astellas Pharma Inc | Composicion farmaceutica que contiene complejo de fragmento fab de anticuerpo antihumano con sitio marcado. |
| MX2021008230A (es) * | 2019-01-07 | 2021-08-11 | Astellas Pharma Inc | Conjugado que comprende ligando y fragmento fab de anticuerpo ceacam5. |
| CN117486698B (zh) * | 2023-10-30 | 2025-08-19 | 国网安徽省电力有限公司电力科学研究院 | 烯醇硅醚类化合物制备c-c键偶联产物的方法与sf6的应用 |
| WO2026151925A1 (en) * | 2025-01-10 | 2026-07-16 | Biogen Ma Inc. | Allyloxycarbonyl reagents, oligonucleotides, and preparation thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5122885A (en) | 1974-08-13 | 1976-02-23 | Sagami Chem Res | Ashiru ll aminosan oo chikanhidorokisamidono seizohoho |
| JPS5910322B2 (ja) * | 1975-07-30 | 1984-03-08 | 三井東圧化学株式会社 | 殺草剤 |
| US4859777A (en) | 1981-07-01 | 1989-08-22 | Eastman Kodak Company | Terpyridine chelating agents |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| AU6621586A (en) | 1985-11-18 | 1987-06-02 | University Of Texas System, The | Polychelating agents for image and spectral enhancement (and spectral shift) |
| DE3768523D1 (de) | 1986-02-18 | 1991-04-18 | Squibb & Sons Inc | ((2,2,2-trichloroethoxy)methoxy)amin. |
| US5064956A (en) | 1987-06-24 | 1991-11-12 | The Dow Chemical Company | Process for preparing mono-n-alkylated polyazamacrocycles |
| IT1224627B (it) | 1988-04-12 | 1990-10-04 | Guidotti & C Spa Labor | Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono. |
| US5087440A (en) | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
| US5089043A (en) | 1989-11-09 | 1992-02-18 | Shionogi & Co., Ltd. | Heterocyclic oxy-phenoxyacetic acid derivatives and their use as herbicides |
| JPH0491070A (ja) | 1990-08-06 | 1992-03-24 | Kanebo Ltd | カリックスアレーン誘導体 |
| US5274129A (en) | 1991-06-12 | 1993-12-28 | Idaho Research Foundation, Inc. | Hydroxamic acid crown ethers |
| GB9115375D0 (en) | 1991-07-17 | 1991-09-04 | Salutar Inc | Compounds |
| US5639746A (en) | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| TW319763B (enExample) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
| EP0955044B1 (en) * | 1995-06-26 | 2005-11-16 | Chelator LLC | Method of inhibiting bacterial or fungal growth using a complexing agent |
| US6461587B1 (en) | 1999-03-22 | 2002-10-08 | Schering Aktiengesellschaft | Perfluoroalkylamides, their production and their use in diagnosis |
| DE19914101C1 (de) * | 1999-03-22 | 2000-10-12 | Schering Ag | Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik |
| US6656448B1 (en) | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
| US6989139B2 (en) | 2000-02-15 | 2006-01-24 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
| US20020002152A1 (en) * | 2000-04-14 | 2002-01-03 | Craig Richard A. | Hydrazide and alkoxyamide angiogenesis inhibitors |
| EP1377321A4 (en) | 2001-02-23 | 2006-01-11 | Bristol Myers Squibb Co | RECOVERY ANTAGONISTS RECEIVING DETECTABLE MACROPHAGE RECEPTORS FOR THE IDENTIFICATION OF ATHEROSCLEROSIS AND VULNERABLE PLAQUE BY IMAGING |
| JP4590157B2 (ja) | 2001-03-21 | 2010-12-01 | アイシス イノヴェイション リミテッド | アッセイ、方法および手段 |
| TWI284539B (en) | 2001-07-30 | 2007-08-01 | Epix Pharm Inc | A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide |
| CA2526760A1 (en) | 2003-05-23 | 2005-01-06 | Epix Pharmaceuticals, Inc. | Optically pure and enriched isomers of chelating ligands and contrast agents |
| US7662856B2 (en) | 2003-08-29 | 2010-02-16 | The University Of Houston System | Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine |
| US20050106100A1 (en) | 2003-09-03 | 2005-05-19 | Harris Thomas D. | Compounds containing matrix metalloproteinase substrates and methods of their use |
| JP4912153B2 (ja) * | 2003-12-01 | 2012-04-11 | イミューノメディクス、インコーポレイテッド | タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法 |
| US20070142417A1 (en) | 2005-05-11 | 2007-06-21 | Aventis Pharmaceuticals Inc | Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor |
| CA2613439A1 (en) | 2005-06-30 | 2007-01-11 | Bristol-Myers Squibb Pharma Company | Hydrazide conjugates as imaging agents |
| US7618957B2 (en) * | 2005-07-15 | 2009-11-17 | Bayer Schering Pharma Aktiengesellschaft | Perfluoroalkyl-containing complexes, process for their production as well as their use |
| KR101861025B1 (ko) * | 2008-01-08 | 2018-05-24 | 랜티우스 메디컬 이메징, 인크. | 영상화 제제로서의 ｎ-알콕시아미드 접합체 |
| US8877157B2 (en) | 2009-07-08 | 2014-11-04 | Lantheus Medical Imaging, Inc. | N-alkoxyamide conjugates as imaging agents |
-
2010
- 2010-07-08 US US13/382,689 patent/US8877157B2/en active Active
- 2010-07-08 WO PCT/US2010/001926 patent/WO2011005322A2/en not_active Ceased
- 2010-07-08 JP JP2012519544A patent/JP5676600B2/ja not_active Expired - Fee Related
- 2010-07-08 EP EP10797455.2A patent/EP2451776B1/en active Active
- 2010-07-08 CN CN201080040596.8A patent/CN102781909B/zh not_active Expired - Fee Related
- 2010-07-08 AU AU2010271097A patent/AU2010271097B2/en not_active Ceased
- 2010-07-08 CA CA2803520A patent/CA2803520C/en not_active Expired - Fee Related
-
2014
- 2014-09-22 US US14/492,896 patent/US9393329B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8623322B2 (en) | Non-invasive diagnostic agents and methods of diagnosing infectious disease | |
| US8435489B2 (en) | Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma | |
| JP6883046B2 (ja) | 長寿命ガドリニウムに基づく腫瘍標的化イメージングおよび治療薬 | |
| RU2019142507A (ru) | Композиции, способы и системы для синтеза и применение визуализирующих средств | |
| JP2009528271A5 (enExample) | ||
| JPH10512584A (ja) | 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用 | |
| RU2017116176A (ru) | Конъюгированные бисфосфонаты для диагностики и терапии заболеваний костей | |
| JP2016521275A5 (enExample) | ||
| JP2016521275A (ja) | 造影製剤および関連する調製方法 | |
| RU2007108762A (ru) | Диагностические соединения | |
| JP2020502131A5 (enExample) | ||
| RU2018118808A (ru) | Сульфатные соли как ускорители времени прохода | |
| JP2006515866A5 (enExample) | ||
| JP2011509294A5 (enExample) | ||
| Zhang et al. | Synthesis and biological evaluation of a novel 99mTc (CO) 3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection | |
| JP2013507345A5 (enExample) | ||
| JPH06340556A (ja) | イメージング剤としての大環状アミノホスホン酸錯体の使用 | |
| JP2018525447A5 (enExample) | ||
| JP6789991B2 (ja) | 癌の早期骨転移の画像診断剤 | |
| JP2008528617A5 (enExample) | ||
| JP2012520855A5 (enExample) | ||
| EP2749295A1 (en) | Radiopharmaceutical and pharmaceutical kit | |
| JP3051591B2 (ja) | タリウム−２０１の容器に対する付着防止剤 | |
| Shiber | Pyomyositis due to anabolic steroid injection | |
| Miller et al. | Pharmacological properties of orally available, amphipathic polyaminocarboxylic acid chelators for actinide decorporation |